Cosentyx unoready 300 MG pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9KH1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $70,011
Award facts
- Contract value 100% obligated
- $70,010.57 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order on January 8, 2026, valued at $70,010.57 for the supply of Cosentyx (secukinumab) 300 mg pen auto-injectors in 2 mL formulation. The contract is firm fixed-price with no set-aside designation, indicating it was competitively awarded. The Defense Logistics Agency (DLA) Troop Support Medical is the funding federal agency, and the place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is anticipated for completion by January 9, 2026, reflecting a rapid fulfillment timeline typical of pharmaceutical supply chain operations.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. The parent company, Cencora, Inc., also maintains a separate $999,999,999.00 IDC with DLA through December 2031. These contracts enable AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, and medical devices to the Defense Health Agency, U.S. Coast Guard, and other federal government healthcare systems. The Cosentyx delivery order demonstrates the company's critical role in supporting military treatment facilities and federal medical institutions with specialized immunosuppressive medications for conditions such as rheumatoid arthritis and psoriasis.
Quick answers
Who was awarded contract SPE2DR26F9KH1?
SPE2DR26F9KH1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 8, 2026.
How much is contract SPE2DR26F9KH1 worth?
The government has obligated $70,011 on SPE2DR26F9KH1.
Is contract SPE2DR26F9KH1 an order under another contract?
Yes. SPE2DR26F9KH1 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9KH1 competed?
The extent of competition for SPE2DR26F9KH1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award